
A 2026 Diabetes Care study links continuous glucose monitor patterns to cardiometabolic risk in adults without diabetes. Learn how to interpret the findings.

In 2026, Diabetes Care published a paper titled “Beyond Traditional Glycemic Measures: CGM Glycemic Profiles Reveal Associations With Cardiometabolic Risk in Individuals Without Diabetes” (DOI 10.2337/dc26-1197). The publication brought new attention to how everyday blood sugar fluctuations might relate to long-term health. The analysis was conducted by researchers at the Boston University Chobanian & Avedisian School of Medicine. It focused entirely on individuals who did not have diabetes or existing cardiovascular disease.
Continuous glucose monitor technology is increasingly discussed outside traditional medical settings as active adults seek to connect glucose changes with lifestyle habits. The current study adds an important layer to this conversation by analyzing specific cardiovascular risks. It evaluated data from approximately 1,300 adults in the Framingham Heart Study. By focusing on a population without existing disease, the research provides a clearer picture of everyday metabolic function.
Traditional blood tests provide a single snapshot of metabolic health. The broader research trend is moving from single measurements such as fasting glucose and HbA1c toward dynamic measures. These new metrics include mean glucose, time above range, and overall glucose variability. This shift allows individuals to observe how their bodies process energy throughout a normal week.
The primary conclusion centered on the amount of time participants spent at higher glucose levels. The study found that higher average glucose and a greater percentage of time above 140 mg/dL were associated with higher risks of hypertension or high cholesterol. The researchers evaluated average glucose, glucose variability, and the overall proportion of time participants spent at these high levels.
According to lead author Bahar Bakhshi, M.S., these results align with a growing body of literature on cross-sectional associations with health outcomes. The report clarified that this was an association study rather than proof of direct causation. The participants did not have cardiovascular disease, but the results highlight potential early warning signs for later metabolic conditions.
Corresponding author Nicole Spartano, Ph.D., explained that analyzing temporal glucose patterns may help identify early or intermittent dysglycemia. While traditional testing methods like fasting plasma glucose and HbA1c provide relatively static measurements, a continuous monitor captures dynamic glucose patterns over time. This dynamic view could eventually characterize metabolic differences across the entire blood sugar continuum. It might eventually support the phenotyping of people who appear healthy under conventional testing but display different daily glucose patterns.
This focus on continuous data relates closely to how we track other health markers. For example, athletes who rely on continuous lipid profiling and sweat sensors understand the value of dynamic feedback. Monitoring these markers over time paints a more comprehensive picture than a single annual test.
The Boston University researchers took a careful approach to evaluating the 1,300 participants. The study was cross-sectional, meaning the reported relationships do not establish that higher glucose directly caused hypertension or high cholesterol. The findings simply identify a strong correlation between high readings and cardiometabolic risk markers.
The research linked these glucose profiles specifically with hypertension and cholesterol risk. It did not attempt to correlate the readings with race results, training adaptation, injury rates, or longevity. The publicly available report does not provide effect sizes, confidence intervals, or a validated clinical risk score for individual athletes.
Because the study participants were healthy adults, the researchers remained appropriately cautious. They noted that the work may inform future research into diabetes and cardiovascular prevention. Additional studies are still needed to draw definitive clinical conclusions. The results do not automatically establish that every healthy endurance athlete should wear a sensor.
For the aging athlete, these findings offer a new way to think about everyday nutrition. The most defensible use of a continuous monitor for a non-diabetic endurance athlete is as a short-term observational tool. Athletes can compare repeated patterns around meals, easy training, sleep, and rest days. A sensor repeatedly showing unusual patterns should prompt a discussion with a qualified clinician.
Commentary from the American Council on Science and Health noted that clinical evidence showing these monitors improve health outcomes in people without diabetes remains scarce. A 2026 review summarized by the same council reported limited evidence for meaningful health improvements. A systematic review of behavioral outcomes did not find statistically significant reductions in body weight, BMI, or daily calorie intake among non-diabetic users. These devices can reveal patterns, but current evidence does not show that reacting to every reading improves health.
Athletes should not use these findings as a reason to suppress carbohydrate intake during demanding training. Carbohydrate remains central to many endurance sessions. A temporary rise in glucose related to exercise or fueling should not automatically be treated as harmful. A continuous monitor measures interstitial glucose rather than blood glucose directly, and readings can lag behind rapidly changing levels during a workout.
Hitting my forties brought a harsh reality check regarding my own recovery and metabolic stress, as track workouts felt significantly heavier the following day. Instead of forcing my old Tuesday and Thursday intensity schedule, I looked at the data on Masters athletes and muscle protein synthesis. I pushed my second hard session to Friday to allow an extra forty-eight hours of low-intensity recovery. My total weekly volume stayed the same, but the quality of my intervals skyrocketed.
This adjustment allowed my body to clear physical stress and return to a healthy baseline. The same principle applies to managing metabolic stress and blood sugar. Consistently raising your glucose through poor lifestyle habits on rest days is vastly different from an acute spike during a hard workout. Building structured habits to improve biological aging markers requires understanding the difference between productive athletic stress and chronic lifestyle stress.
Athletes must be particularly cautious about interpreting exercise-related glucose changes in isolation. Training, recent meals, and glycogen availability can all influence sensor readings. Hydration, daily stress, and ambient heat also impact the data. The sources available do not establish a validated interpretation framework for asymptomatic endurance athletes.
A higher glucose reading after a carbohydrate-rich meal or during exercise is not evidence of disease. The significance of a pattern depends on clinical context, repeated observations, and laboratory testing. Symptoms and overall cardiometabolic risk also play major roles.
A sensor cannot independently diagnose insulin resistance, hypertension, or high cholesterol. For a midlife athlete, these observations must complement conventional preventive care. This preventive care includes blood pressure assessment, lipid testing, and standard glucose testing. A thorough medical history and discussion of family risk remain equally important.
If a sensor repeatedly suggests unusual patterns, the actionable next step is confirmation by a clinician. Self-diagnosis or aggressive dietary restriction is never the recommended path. A more useful perspective is evaluating whether your everyday fueling supports both immediate performance and long-term cardiovascular health. You want to avoid chronically under-fueling while maintaining energy for key sessions.
You also want to avoid relying heavily on refined carbohydrates outside of designated training windows. When paired with proper timing, managing your nutrition can be as strategic as managing caffeine for endurance performance. The ultimate goal is to fuel the necessary physical work while proactively protecting your cardiovascular longevity.
Endurance athletes may benefit from thinking about fueling as a year-round cardiometabolic strategy. Nutrition should not merely be a race-day performance tactic. The current paper is therefore better understood as a risk-association and measurement study. It is not evidence that recreational monitor use prevents cardiovascular disease or improves athletic performance.
Endurance athletes can use glucose monitoring to observe long-term fueling patterns, but these devices should supplement rather than replace proper medical evaluation and structured carbohydrate intake during training.
Follow ReEndure for practical insights on endurance training, recovery, nutrition and healthy aging. Stay connected for new articles, research led guidance and ideas to help you perform better for longer.



Read practical ideas on endurance training, recovery, nutrition and healthy aging to keep progressing for years to come.
Read the Blog